Millions Take Fish Oil For Brain Health. A Two-year Study Found No Benefit

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

In a two-year randomized trial, older adults at elevated risk of Alzheimer’s who took daily DHA fish oil did not perform better on cognitive tests or show less hippocampal shrinkage than participants given a placebo. DHA levels in their cerebrospinal fluid rose, but the findings apply to this study group and do not establish whether fish consumption or other dietary patterns affect brain health.

A two-year clinical trial found that daily fish oil supplements did not measurably improve memory or other cognitive abilities, or prevent shrinkage in a brain region involved in memory, among 365 adults ages 55 to 80 at elevated risk of Alzheimer’s disease. The study, led by researchers at Keck Medicine of USC and published in eBioMedicine, found that supplement users had higher DHA levels in cerebrospinal fluid but no significant advantage over those given a placebo.

Participants were randomly assigned to take a daily supplement containing 2,000 milligrams of DHA, an omega-3 fatty acid, or an inactive placebo. The trial was double-blind, meaning participants and researchers did not know who was receiving the supplement during the study. All participants rarely ate fish, a major dietary source of omega-3s, and were considered at increased risk of developing Alzheimer’s.

Researchers checked whether the supplement’s DHA reached the central nervous system by measuring its concentration in cerebrospinal fluid, the liquid surrounding the brain and spinal cord. After six months, DHA levels in that fluid had risen by an average of 17% among those taking supplements. But when researchers assessed cognition over two years, supplement users showed no significant advantage over the placebo group.

Brain imaging also found no evidence that DHA supplements prevented shrinkage of the hippocampus, a region involved in forming and organizing memories. The study’s reported findings concern measurable outcomes in this group; they do not show that omega-3s have no role in brain biology or that every possible outcome of fish oil use was tested.

What the Trial Says About DHA

The results challenge the expectation that raising omega-3 levels with a supplement will, by itself, protect memory as people age. In this trial, researchers established that DHA levels in cerebrospinal fluid increased, but that change did not correspond to measurable gains on cognitive tests or less hippocampal shrinkage over two years. That distinction matters: evidence that a nutrient reaches the brain is not the same as evidence that supplementation improves brain health.

The finding is relevant to consumers because fish oil is widely used with the aim of supporting cognition, while Americans spend more than $1 billion a year on supplements containing omega-3 fatty acids, according to the source report. The study does not assess every fish oil product, dose, duration, population, or reason for taking supplements. It does, however, provide a controlled comparison for a specific high-risk group and a substantial daily DHA dose.

For people making decisions about supplements, the result argues against treating this regimen as a proven Alzheimer’s prevention strategy. It is a study finding, not individualized medical guidance; people with questions about supplements or health conditions can discuss them with a qualified health professional.

Who Took Part in the Trial

The researchers enrolled 365 adults ages 55 to 80 who rarely ate fish and were considered at elevated risk of Alzheimer’s disease. Nearly half, or 47%, carried the APOE4 gene variant, which is associated with increased risk of late-onset Alzheimer’s. Carrying APOE4 does not mean a person will necessarily develop the disease.

The trial compared daily DHA supplementation with a placebo and followed participants for two years. Investigators measured cognition at the start and again during the study, and used brain imaging to examine hippocampal volume. The cerebrospinal-fluid DHA measurement was taken after six months to test whether supplementation increased levels in the central nervous system.

The report notes that omega-3s are important components of brain cell membranes and support normal neuronal function. It also describes earlier research linking a Mediterranean-style dietary pattern—which includes fish alongside vegetables, fruit, whole grains, legumes, nuts, and olive oil—with lower Alzheimer’s risk. Such associations do not establish that fish oil supplements produce the same effects as a whole dietary pattern.

Questions Beyond This Study

The trial does not settle whether eating fish, following a broader dietary pattern, or taking omega-3s earlier in life affects cognitive health. Participants were older adults who rarely ate fish and were selected for elevated Alzheimer’s risk, so the findings cannot automatically be applied to people with different diets, ages, or risk profiles. The study also ran for two years; the source report does not establish whether a longer period would produce different outcomes.

The results show no significant benefit on the measured cognitive tests and hippocampal shrinkage outcomes, not that supplements had no biological effect: cerebrospinal-fluid DHA rose. The report does not provide enough detail to determine whether particular subgroups, including people with APOE4, responded differently. It also does not establish why the increase in DHA failed to translate into measurable benefits.

Researchers Examine How DHA Works

Yassine and colleagues are investigating how the brain absorbs, processes, and uses omega-3 fatty acids, according to the report. They are examining whether factors such as dietary pattern, overall health, genetic risk, and age affect how the brain responds to DHA. The researchers have suggested that omega-3s may act differently when consumed as part of a broader diet than when taken in isolation, but the trial did not test that explanation.

The source report does not give a date for further results or identify a next trial milestone. Until additional evidence is available, the current conclusion remains specific: daily DHA supplements did not produce measurable cognitive or hippocampal benefits over two years in the older adults studied.

Key Questions

Did fish oil improve memory in the study?

No significant cognitive advantage was found for participants taking daily DHA supplements compared with those given a placebo over two years.

Did the supplement reach participants’ brains?

DHA levels in cerebrospinal fluid, which surrounds the brain and spinal cord, increased by an average of 17% after six months among participants taking the supplement. That increase did not produce measurable cognitive benefits in the trial.

Did fish oil prevent brain shrinkage?

No. Brain imaging found no evidence that the supplements prevented shrinkage of the hippocampus, a region involved in memory.

Does the study show that eating fish cannot support brain health?

No. The trial tested a daily DHA supplement in older adults who rarely ate fish. It did not compare fish consumption with a low-fish diet or test a Mediterranean-style eating pattern.

Who was included in the study?

The study enrolled 365 adults ages 55 to 80 who rarely ate fish and were considered at elevated risk of Alzheimer’s disease. Nearly half carried APOE4, a genetic risk variant; its presence does not mean a person will inevitably develop Alzheimer’s.

Source: rss